Autophagy is a premier peer-reviewed journal published by Taylor & Francis, Inc. in the United States, focusing on advances in the fields of Cell Biology and Molecular Biology. With an impressive impact factor reflected in its Q1 ranking in both categories, Autophagy stands as a vital resource for researchers and professionals dedicated to understanding the intricate mechanisms of cellular degradation and recycling. The journal has been a cornerstone of scientific communication since its inception in 2005, continuing to flourish through 2024, fostering collaboration and innovation in the study of autophagic processes. Although it does not currently offer Open Access options, the journal remains highly regarded for its rigorous peer-review process and its commitment to publishing high-quality, impactful research. By bridging fundamental research with clinical applications, Autophagy plays a crucial role in advancing our understanding of various diseases, making it an essential tool for scholars and practitioners in the biomedical field.

JOURNAL OF PINEAL RESEARCH, published by Wiley, is a leading peer-reviewed journal dedicated to advancing the field of endocrinology with a specific focus on the pineal gland and its significant roles in various physiological processes and disorders. Since its inception in 1984, the journal has established itself as a crucial platform for the dissemination of high-quality research, securing an impressive Q1 ranking in Endocrinology as of 2023, with Scopus rankings placing it among the top 5% of journals in the biochemistry, genetics, and molecular biology category. With an emphasis on original research articles, reviews, and letters in the areas of melatonin, circadian rhythms, and neuroendocrine regulation, the journal aims to foster interdisciplinary collaboration and knowledge-sharing among researchers, professionals, and students alike. Although not an open-access journal, its rigorous editorial process and wide-reaching impact factor ensure that published work reaches a global audience, making it an invaluable resource for those in the scientific community committed to the study of endocrinology and beyond.

PHYSIOLOGY & BEHAVIOR, published by Pergamon-Elsevier Science Ltd, is a premier journal that has been illuminating the intersections of physiological and behavioral research since its inception in 1966. With a promising impact reflected in its 2023 category quartiles— ranking Q2 in both Behavioral Neuroscience and Experimental and Cognitive Psychology, and a prior Q1 in Philosophy—this journal stands at the forefront of multidisciplinary research. It holds respectable ranks within the Scopus database, placing 27th out of 165 in Experimental Psychology and 25th out of 88 in Behavioral Neuroscience, highlighting its significant contribution to the academic community. The journal encourages the dissemination of high-quality research objectives that explore the intricate connections between behavior and biological processes, making it a vital resource for researchers, professionals, and students alike. Although access is not currently open, the journal continues to provide deep insights into crucial developments in its field, ensuring its readers stay updated on the latest scientific advancements.

BIOCHEMICAL SOCIETY TRANSACTIONS is a premier journal published by Portland Press Ltd, renowned for its rigorous dissemination of cutting-edge research in the field of biochemistry. Established in 1973 and currently spanning until 2024, this journal has solidified its standing with an impressive Q1 category ranking in Biochemistry, reflecting its commitment to high-quality scholarship and innovation. It plays a crucial role in bridging current biochemical research with its practical applications, making it an invaluable resource for researchers, professionals, and students alike. The journal enjoys a commendable position in the Scopus Ranks, sitting at Rank #105 out of 438 journals in its category, placing it in the 76th percentile among similar publications. While the journal maintains a subscription-only access policy, it promises to provide readers with comprehensive insights and discoveries that drive advancements in biochemistry and related fields. This journal is not just a repository of information; it is a vibrant community dedicated to the progress of biochemistry, making it essential reading for anyone involved in this dynamic discipline.

Welcome to the Korean Journal of Physiology & Pharmacology, a pivotal academic platform dedicated to advancing the disciplines of physiology and pharmacology. Published by the esteemed Korean Journal of Physiology & Pharmacology, this journal has been disseminating valuable research findings since its inception in 1997 and continues to be a critical resource for researchers, professionals, and students in South Korea and beyond. With an ISSN of 1226-4512 and E-ISSN of 2093-3827, it offers insights into various aspects of drug action and physiological mechanisms. Although this journal currently does not subscribe to Open Access, it plays a vital role in bridging the gap between experimental and clinical studies, receiving commendations for its quality. In the 2023 Scopus rankings, it is notably positioned in the Q3 quartile for Pharmacology and Q4 for Physiology, reflecting its commitment to excellence. As the journal converges towards its comprehensive coverage in 2024, it remains a cornerstone for those looking to engage deeply with critical developments in these fields.

JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, published by BIOLIFE SAS, is a pivotal platform in the fields of Cancer Research, Endocrinology, Immunology, and Physiology, addressing fundamental aspects of biological regulation and homeostasis. Since its inception in 1987, this journal has consistently contributed to the advancement of knowledge, showcasing innovative research and breakthroughs that are instrumental for professionals, researchers, and students alike. Although categorized in the Q4 quartile across multiple disciplines, the journal offers a unique perspective that encourages exploration into underrepresented areas, underscoring its role in fostering scientific dialogue and collaboration. With ISSN 0393-974X and E-ISSN 1724-6083, the journal remains a crucial resource for those invested in understanding the complexities of homeostatic agents and their implications in health and disease. Based in Silva Marina, Italy, it invites contributions that broaden the horizons of contemporary biomedical research.

NEURAL PLASTICITY is a distinguished open access journal published by Hindawi Ltd, focusing on innovative research in the field of neurology and neuroscience. With its ISSN 2090-5904 and E-ISSN 1687-5443, this journal has been a vital resource for researchers since its inception in 1989, providing high-quality content that bridges the gap between theoretical and clinical aspects of neural plasticity. The journal is recognized with a 2023 category quartile ranking of Q2 in both Neurology and Clinical Neurology, confirming its relevance and impact within the academic community. NEURAL PLASTICITY is ranked 85th out of 400 in Medicine: Neurology (Clinical) and 46th out of 192 in Neuroscience: Neurology on Scopus, placing it in the 78th and 76th percentiles respectively. This makes it a significant platform for publishing cutting-edge research that informs clinical practices and enhances our understanding of neural mechanisms. Researchers, professionals, and students can access a wealth of studies that contribute to the evolving discussion on neural adaptation, recovery, and therapeutic interventions, making NEURAL PLASTICITY an essential addition to the libraries of those dedicated to advancing neurological science.

STRESS - THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS, published by Taylor & Francis Ltd, is an esteemed open-access journal dedicated to advancing our understanding of stress and its biological underpinnings. Established in 1996 and continuing until 2024, this journal is pivotal in the exploration of stress across multiple dimensions, including its impact on mental health, neurobiology, and endocrine systems. With an impressive categorization in Q2 and Q3 quartiles across various fields such as Behavioral Neuroscience, Psychiatry, and Physiology, STRESS ranks commendably within its discipline, positioning itself as a vital resource for researchers and professionals alike. As of 2022, the journal's open access policy enhances visibility and accessibility, fostering a broader dissemination of knowledge. The journal invites submissions from a diverse range of disciplines, aiming to bridge gaps across fields and encourage interdisciplinary collaboration. By addressing the multifaceted nature of stress, STRESS remains essential for those eager to contribute to this dynamic and critical area of research.

SYNAPSE, an esteemed journal in the field of Cellular and Molecular Neuroscience, is published by Wiley and serves as a vital platform for disseminating groundbreaking research in neuroscience. Established in 1987, this journal has been pivotal in exploring the intricate mechanisms governing synaptic function and neural communication, contributing to our understanding of the nervous system. With an ISSN of 0887-4476 and an E-ISSN of 1098-2396, SYNAPSE is indexed in Scopus and currently holds a Q4 quartile ranking in its category, reflecting its niche yet significant presence within the research community. Despite its recent ranking in the 21st percentile among its peers, the journal’s commitment to quality and innovation remains unwavering. It is published from Hoboken, New Jersey, and although it is not an open-access journal, it provides invaluable insights and critical reviews that are pivotal for researchers, professionals, and students alike who seek to advance their knowledge in the dynamic field of neuroscience. Join us in contributing to the ever-evolving discourse in cellular and molecular neuroscience through SYNAPSE.

The JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, published by the American Society for Pharmacology and Experimental Therapeutics, stands as a pivotal platform in the fields of pharmacology and molecular medicine. With an impressive convergence of knowledge from 1945 to 2024, this esteemed journal is recognized for its rigorous peer-reviewed research, contributing significantly to our understanding of drug action and therapeutic interventions. It holds a commendable position in the Q2 quartile in both Molecular Medicine and Pharmacology, emphasizing its relevance and impact within the contemporary scientific landscape, as evidenced by its Scopus ranking that places it amongst the leading journals in its category. Aimed at researchers, professionals, and students, the journal not only fosters a deeper insight into toxicology, pharmacodynamics, and therapeutic strategies but also encourages innovation through its comprehensive access to groundbreaking experimental methodologies. The journal continues to foster discourse and disseminate research that shapes the future of pharmacological science.